Navigation Links
New Data Analyses on CONCERTA® Pediatric Treatment Include Insight on Handwriting Performance and Attention in ADHD
Date:10/29/2010

percent or more of patients in either sub-analysis presented today were consistent with those previously reported for CONCERTA® and included decreased appetite, upper abdominal pain, headache, irritability and initial insomnia. Two patients discontinued due to adverse events. No serious adverse events or deaths were reported.

About the CONCERTA® Clinical Trials The two posters presented today are secondary analyses taken from a data set comprised of two randomized, double-blind, placebo-controlled, crossover analog simulated-classroom trials examining the effects of CONCERTA® compared with placebo. The trials included a general population of children with ADHD and a wide range of endpoints based on standardized ADHD measurements, as well as observational input from subjects' parents, teachers and healthcare providers.  

About ADHDAttention Deficit Hyperactivity Disorder (ADHD) is a common and treatable medical condition characterized by inattention, hyperactivity and impulsivity that is estimated to affect about 5 million children(4) and 8 million adults(5) in the United States. While the exact cause of the condition is still unknown, scientists have focused their research on chemical messengers, or neurotransmitters, in the brain.(6)   Studies suggest that 76 percent of ADHD is linked to family genetics,(6) so the condition may be more common among people who have a close relative with ADHD.(7)

About CONCERTA®CONCERTA® is a prescription medication approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children, adolescents and adults ages 6 to 65, as part of a total treatment program that may include counseling or other therapies.

IMPORTANT SAFETY INFORMATIONTalk to your healthcare professional for a proper diagnosis and treatment of ADHD.  Only a healthcare professional can decide whether medication is right for you or your child.

CONCERTA®
'/>"/>

SOURCE McNeil Pediatrics(TM)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress
2. Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses
3. The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports
4. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
5. Results and Additional Analyses From Study Show That Cortheras Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables
6. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
7. New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
8. Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
9. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
10. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... analysis of Centers for Medicare and Medicaid Services, (CMS) ... percent of seniors chose lower-cost preferred pharmacy plans that ... The findings were released by Drug Channels . ... of Medicare Part D," said Pharmaceutical Care Management Association ...
(Date:1/23/2015)... YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ... board of directors of Advaxis, Inc. ("Advaxis" or the ... board has breached its fiduciary duties to shareholders. ... on an investing website reporting that Advaxis had misrepresented ...
(Date:1/23/2015)... Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the number of ... compound, LB‑100, is being conducted, has been expanded from 1 ... M.D., the founder and President of Lixte, said that, "the ... site. Accrual of patients, however, was slower than projected. The ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... WASHINGTON, June 15, 2011 A new ad campaign launched ... country have in finding savings for their state,s Medicaid program: ... drugstores. States and the federal government could save $33 ... overpayments and modernizing pharmacy benefits to be more like those ...
... 2011 MedNet Solutions, a global life sciences technology ... pleased to announce that MedNet will be showcasing its ... Drug Information Association (DIA) Annual Meeting in Chicago, IL ... the commercial release of iMedNet EDC earlier this year, ...
Cached Medicine Technology:The Medicaid Choice: Cut Benefits for Patients or Overpayments to Independent Drugstores 2MedNet Solutions to Showcase Its Complete Suite of eClinical Solutions at the 47th DIA Annual Meeting 2
(Date:1/22/2015)... January 22, 2015 Blue Cross and Blue ... who exemplify what it means to “Live Fearless.” ... people to share their stories about how they or someone ... inspired others by living in the moment. By telling these ...
(Date:1/22/2015)... A new white paper by The Beryl Institute ... long-term care environment as well as provides recommendations for ... “The Power of Person-Centeredness in Long-Term Care: A View ... patient, resident and family experience in long-term care and ...
(Date:1/22/2015)... has released a new blog post presenting the basic features ... Purchasing an accidental death and dismemberment rider for a car ... provides benefits if the insured dies in an accident. Accidental ... life insurance. , AD&D is not expensive and can ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... annual revenues in the past three years. Today, the business ... , According to the sales manager of the company, this ... in 2015. This point can be reflected on the discounted ...
(Date:1/22/2015)... January 22, 2015 EBSCO Information Services ... are expanding their relationship in an effort to further promote ... world. While EBSCO has long made AMA journals available via ... agent for The JAMA Network. , Long known ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... Blood-lead Tests to Pregnant Women and Young Children , ... today reminded Pennsylvania parents to test young children for ... Week, Oct. 18-24. , "Parents and caregivers need ... tested for lead poisoning," said Secretary of Health Everette ...
... Contrary to what was previously assumed, overweight is not increasing ... of the Faculty of Mathematics, Computer Science, and Natural Sciences ... and other results in the current issue of Deutsches ... 641𔃆)., Most Germans are overweight, with a body mass index ...
... (HAART) to treat HIV-1 infection are less likely than ... through breastfeeding, according to a new study. The findings, ... The Journal of Infectious Diseases , suggest HAART ... eligible mothers in areas with limited resources, such as ...
... ... keeps students informed to combat flu , ... Victoria, BC (PRWEB) October 16, 2009 -- While most Canadians ... still a very real health concern. That’s why University Canada West is keeping its ...
... cost for sugary drinks haven,t slowed obesity epidemic, study finds ... taxes and levies on soft drinks are slowing consumption, but ... States, researchers say. , In an analysis of 16 years ... soft drink taxation affected body mass index, researchers found that ...
... Medifast, Inc. (NYSE: MED ), a provider of leading ... one of "America,s 200 Best Small Companies" by Forbes magazine. ... has recognized Medifast, advancing to number 16 on the list ... the article Forbes states, "Our list of the 200 Best ...
Cached Medicine News:Health News:Pennsylvania Observes National Lead Poisoning Prevention Week 2Health News:Maternal HIV-1 treatment protects against transmission to newborns 2Health News:Schools Still on Alert for H1N1 Outbreaks 2Health News:Soda Taxes Not Making a Dent in U.S. Waistlines 2Health News:Medifast, Inc. Named by Forbes as One of 'America's 200 Best Small Companies' 2Health News:Medifast, Inc. Named by Forbes as One of 'America's 200 Best Small Companies' 3
... new highly sensitive and specific second-generation peptide-based ... on the detection of autoantibodies against the ... residues in human serum or plasma. Enabling ... Anti-CCP assay provides an additional tool in ...
Latex agglutination inhibition slide test for the qualitative detection of hCG in urine....
Color-enhanced slide test for the rapid qualitative and semi-quantitative detection of antibodies to streptococcal extracellular antigens in serum, plasma and peripheral blood....
Latex agglutination slide test for the qualitative and quantitative detection of rubella virus antibody in serum....
Medicine Products: